Gary Y. Yang

发表

Renal atrophy secondary to chemoradiotherapy of abdominal malignancies.

Charles R. Thomas, G. Wilding, M. Fakih, 2010, International journal of radiation oncology, biology, physics.

Positron emission tomography's changing significance in the treatment of esophageal cancer.

S. Hopkins, Gary Y. Yang, 2009, World journal of gastrointestinal oncology.

Neoadjuvant chemoradiation for rectal cancer: is more better?

M. Fakih, Gary Y. Yang, Anushree Patel, 2008, Oncology.

Intensity modulated radiation therapy in the treatment of esophageal cancer

Gary Y. Yang, H. Malhotra, J. Yap, 2010, Thoracic cancer.

Does circular stapled esophagogastric anastomotic size affect the incidence of postoperative strictures?

H. Nava, T. Demmy, S. Yendamuri, 2011, The Journal of surgical research.

Association of Technetium(99m) MAG-3 renal scintigraphy with change in creatinine clearance following chemoradiation to the abdomen in patients with gastrointestinal malignancies.

Charles R. Thomas, H. Nava, G. Wilding, 2010, Journal of gastrointestinal oncology.

Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy.

Y. Li, E. Repasky, Gary Y. Yang, 2006, Vaccine.

The Role of Radiation in the Perioperative Treatment of Esophagogastric Cancer

K. May, N. Khushalani, Gary Y. Yang, 2011, Current Treatment Options in Oncology.

The Role of Gemcitabine in Combined Modality Therapy

H. Choy, W. Blackstock, Gary Y. Yang, 2003 .

Chemotherapy-Induced Carcinoembryonic Antigen Surge in Patients with Metastatic Colorectal Cancer

Judy L. Smith, M. Fakih, A. Rajput, 2006, Oncology.

The role of positron emission tomography in esophageal cancer.

Charles R. Thomas, B. Jobe, Gary Y. Yang, 2008, Gastrointestinal cancer research : GCR.

Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma.

M. Fakih, Y. Rustum, A. Rajput, 2008, International journal of radiation oncology, biology, physics.

A Phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma.

Judy L. Smith, M. Fakih, Y. Rustum, 2006, International journal of radiation oncology, biology, physics.

Proton therapy for gastrointestinal cancers

J. Slater, Gary Y. Yang, T. Ling, 2012 .

Principles of modern radiation techniques for esophageal and gastroesophageal junction cancers.

N. Khushalani, Gary Y. Yang, Susan A McClosky, 2009, Gastrointestinal cancer research : GCR.

Proton stereotactic body radiation therapy for liver metastases-results of 5-year experience for 81 hepatic lesions.

C. Hsueh, J. Slater, M. Reeves, 2021, Journal of gastrointestinal oncology.

Pure Tubular Breast Carcinoma: A 34 year Study of Outcomes

Gary Y. Yang, Shaneli A Fernando, J. Landry, 2008, The breast journal.

High SOD and low GPX activities in RBC predict susceptibility of lung cancer patients to radiation pneumonitis

C. Ip, Jihnhee Yu, Young-Mee Park, 2007 .

FDG PET imaging in the staging and management of gastric cancer.

S. Hopkins, Gary Y. Yang, 2010, Journal of gastrointestinal oncology.

Palliation of malignant dysphagia in esophageal cancer: a literature-based review.

H. Nava, M. Javle, C. Nwogu, 2006, The journal of supportive oncology.

Chemoradiation is a tolerable therapy for older adults with esophageal cancer.

G. Wilding, R. Iyer, M. Javle, 2005, Anticancer research.

Benefits and challenges of radiation therapy in gastric cancer: techniques for improving outcomes.

S. McCloskey, Gary Y. Yang, 2009, Gastrointestinal cancer research : GCR.

Accomplishments in 2008 in the management of esophageal cancer.

K. Ott, Gary Y. Yang, 2009, Gastrointestinal cancer research : GCR.

A phase I trial of Proton stereotactic body radiation therapy for liver metastases.

C. Hsueh, A. Wroe, J. Slater, 2018, Journal of gastrointestinal oncology.

Management of anal cancer in 2010. Part 1: Overview, screening, and diagnosis.

M. Fakih, Gary Y. Yang, A. Abbas, 2010, Oncology.

Management of anal cancer in 2010. Part 2: current treatment standards and future directions.

M. Fakih, Gary Y. Yang, A. Abbas, 2010, Oncology.

Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer.

G. Wilding, G. Warren, K. May, 2013, Journal of gastrointestinal oncology.

Long-term Outcome of Stage I Seminoma

M. Kuettel, Gary Y. Yang, Baoqing Li, 2007, American journal of clinical oncology.

Surgical and radiation therapy management of recurrent anal melanoma.

J. Slater, J. Slater, M. Senthil, 2014, Journal of Gastrointestinal Oncology.

Treatment Factors Associated With Overall Survival in Retroperitoneal Sarcoma: An Institutional Review

M. Reeves, Matthew J. Selleck, M. L. Kwong, 2020, The American surgeon.

Proton therapy for esophageal cancer

J. Slater, Gary Y. Yang, Joseph I. Kang Jr, 2012, Thoracic cancer.

Can the sequencing of concurrent capecitabine and radiation therapy improve the therapeutic ratio in rectal cancer?

Charles R. Thomas, Gary Y. Yang, 2007, Gastrointestinal cancer research : GCR.

Analysis of clinical and dosimetric factors associated with change in renal function in patients with gastrointestinal malignancies after chemoradiation to the abdomen.

G. Wilding, M. Fakih, K. May, 2010, International Journal of Radiation Oncology, Biology, Physics.

Review: neoadjuvant chemoradiotherapy and chemotherapy improve survival in operable esophageal cancer.

M. Javle, Gary Y. Yang, 2007, ACP journal club.

Proton Therapy: A New Dawn for Gastrointestinal Cancer Treatment

Gary Y. Yang, J. Landry, 2015 .

Individualized 4-dimensional computed tomography proton treatment for pancreatic tumors.

J. Slater, Gary Y. Yang, A. Vassantachart, 2016, Journal of gastrointestinal oncology.

Erlotinib and Radiation Therapy for Elderly Patients with Esophageal Cancer - Clinical and Correlative Results from a Prospective Multicenter Phase 2 Trial

C. LeVea, R. Iyer, N. Khushalani, 2013, Oncology.

Pilot Study of Gefitinib, Oxaliplatin, and Radiotherapy for Esophageal Adenocarcinoma: Tissue Effect Predicts Clinical Response

H. Nava, G. Wilding, J. Black, 2008, American journal of clinical oncology.

Multimodality approaches for rectal cancer.

Charles R. Thomas, Gary Y. Yang, T. Wagner, 2004, Current problems in cancer.

In Situ Vaccination with CD204 Gene-Silenced Dendritic Cell, not Unmodified Dendritic Cell, Enhances Radiation Therapy of Prostate Cancer

P. Fisher, B. Foster, R. Mikkelsen, 2012, Molecular Cancer Therapeutics.

Multimodality Approaches for Pancreatic Cancer

M. Fuss, Gary Y. Yang, T. Wagner, 2005, CA: a cancer journal for clinicians.

Aorto-esophageal fistula: a rare fatal case caused by esophageal malignancy.

H. Nava, S. Yendamuri, N. Khushalani, 2010, Journal of gastrointestinal oncology.

High superoxide dismutase and low glutathione peroxidase activities in red blood cells predict susceptibility of lung cancer patients to radiation pneumonitis.

C. Ip, Jihnhee Yu, Young-Mee Park, 2007, Free radical biology & medicine.

Palliative radiation therapy for primary gastric melanoma.

J. Slater, J. Slater, Gary Y. Yang, 2014, Journal of gastrointestinal oncology.

Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity.

Joseph Y Ting, N. Esiashvili, C. Staley, 2002, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Cancer immunotherapy and heat-shock proteins: promises and challenges

M. Manjili, Gary Y. Yang, J. Subjeck, 2004, Expert opinion on biological therapy.

The role of chemotherapy and radiation in the treatment of locally advanced non-small cell lung cancer (NSCLC).

Gary Y. Yang, T. Wagner, 2010, Current drug targets.

Misrepresentation of publications among radiation oncology residency applicants.

M. Kuettel, M. Schoenwetter, Gary Y. Yang, 2006, Journal of the American College of Radiology : JACR.

Analysis of Intensity-Modulated Radiation Therapy (IMRT), Proton and 3D Conformal Radiotherapy (3D-CRT) for Reducing Perioperative Cardiopulmonary Complications in Esophageal Cancer Patients

J. Slater, R. Grove, Gary Y. Yang, 2014, Cancers.

Management of stage II/III rectal cancer.

M. Fakih, Gary Y. Yang, T. Wagner, 2010, Journal of gastrointestinal oncology.

Induction chemotherapy with nedaplatin with 5-FU followed by intensity-modulated radiotherapy concurrent with chemotherapy for locoregionally advanced nasopharyngeal carcinoma.

Zhimin Zhang, Chuan Chen, Ge Wang, 2010, Japanese journal of clinical oncology.

Particle Radiation Therapy for Liver Tumors: Simulation and Treatment Planning

A. Wroe, Gary Y. Yang, Matthew L Knecht, 2017 .

Stereotactic body proton therapy for liver metastases

J. Slater, Gary Y. Yang, T. Ling, 2012 .

Proton therapy for hepatocellular carcinoma

J. Slater, Gary Y. Yang, D. Bush, 2012 .

Proton therapy for hepatocellular carcinoma.

J. Slater, Gary Y. Yang, D. Bush, 2012, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer

I. Yeo, R. Schulte, Gary Y. Yang, 2015, Radiation oncology.

Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience.

G. Wilding, G. Warren, K. May, 2012, Journal of gastrointestinal oncology.

Principles and techniques of radiation therapy for esophageal and gastroesophageal junction cancers.

M. McAleer, C. Willett, J. Hayman, 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

Concurrent Oxaliplatin, 5-Fluorouracil, and Radiotherapy in the Treatment of Locally Advanced Esophageal Carcinoma

H. Nava, M. Javle, Gary Y. Yang, 2007, Cancer journal.

Role of lymph node ratio in selection of adjuvant treatment (chemotherapy vs. chemoradiation) in patients with resected gastric cancer.

M. Reeves, Matthew J. Selleck, M. Senthil, 2018, Journal of gastrointestinal oncology.

Capecitabine, Oxaliplatin and Radiotherapy: A Phase IB Neoadjuvant Study for Esophageal Cancer with Gene Expression Analysis

H. Nava, G. Wilding, C. LeVea, 2009, Cancer investigation.

Side effects of therapy: case 3. Gastric cancer after radiotherapy of pediatric Hodgkin's disease.

M. Javle, Gary Y. Yang, J. Palesty, 2004, Journal of Clinical Oncology.

Clinical T2N0M0 carcinoma of thoracic esophagus.

N. Khushalani, Gary Y. Yang, T. Wagner, 2010, Journal of thoracic disease.

Surgical resection after TNFerade therapy for locally advanced pancreatic cancer.

C. LeVea, J. Gibbs, R. Iyer, 2009, JOP : Journal of the pancreas.

Positron emission tomography as predictor of rectal cancer response during or following neoadjuvant chemoradiation.

M. Fakih, S. Hopkins, Gary Y. Yang, 2010, World journal of gastrointestinal oncology.

Safety and efficacy of first-line chemotherapy in unresected metastatic colorectal cancer.

Judy L. Smith, G. Wilding, M. Fakih, 2007, Clinical colorectal cancer.

Change in CA 19-9 Levels after Chemoradiotherapy Predicts Survival in Patients with Locally Advanced Unresectable Pancreatic Cancer

G. Wilding, K. May, W. Ma, 2010 .

Proton SBRT for Liver Metastases - Results of 5-year Experience for 80 Hepatic Lesions Based on NRG-BR001

C. Hsueh, J. Slater, M. Reeves, 2018, International Journal of Radiation Oncology*Biology*Physics.

Should preoperative, post-chemoradiotherapy endoscopy be routine for esophageal cancer patients?

H. Nava, T. Demmy, Aasma Shaukat, 2004, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Prophylactic cranial irradiation in small-cell lung cancer.

G. Yang, Gary Y. Yang, R. Matthews, 2000, The oncologist.

Image-Guided Proton Therapy: A Comprehensive Review

J. Slater, Gary Y. Yang, Shelby A. Lane, 2023, Cancers.

A phase I and biological correlates study of capecitabine (CAP) + oxaliplatin (OX) + radiation therapy (RT) in locally advanced rectal cancer (LARC)

Judy L. Smith, M. Fakih, Y. Rustum, 2005 .

Gene expression profile (GEP) for the prediction of pathologic complete response (pCR): Preliminary data from a neoadjuvant study of capecitabine (C), oxaliplatin (OXP), and radiation (RT) for esophageal cancer (EC).

H. Nava, J. Miecznikowski, S. Yendamuri, 2010 .